Clinical Trials
WANTED:
This study is funded by the Insulin Dependent Diabetes Trust and the Midwest Pain Society.
This study is being conducted at Rosalind Franklin University under the direction of John W. Burns, Ph.D. and at the Pain and Rehabilitation CLinic of Chicago under the direction of Kenneth L. Lofland, Ph.D.
In this study, you will be asked to either learn and practice relaxation techniques or talk to an experimenter and keep a daily activity log.
The study requires 6 visits, lasting 45 minutes to 1.5 hours in duration at one of the following centers of your choice:
Pain and Rehabilitation Clinic of Chicago (640 N. LaSalle, Chicago, IL)
Rosalind Franklin University (3333 N. Green Bay Rd., North Chicago, IL)
You will also be asked to fill out questionnaires that will be mailed to you with a stamped, addressed envelope 3 months after your last scheduled visit.
We will pay you up to $15 each session for transportation and/or parking, $10 at the completion of each session, and an additional $25 after you mail your final packet of questionnaires.
For further information, Contact Angela or Traci:
DPNstudy@gmail.com
312-445-0644
Please give your name and phone number.
WANTED:
Type 2 Online Study Volunteers
Brian Vandenberg, Ph.D., a researcher with the University of
Missouri-St. Louis, and Rachel Hibberd, a doctoral graduate student,
are conducting a brief online study of religious coping with Type 2
Diabetes. Anyone who has been diagnosed with Type 2 Diabetes and is
over eighteen years old is eligible to participate by completing a brief
online survey.
All participants will be entered in a raffle for a $100 gift certificate
to Amazon.com.
If you have questions about the study, please email BVanden@umsl.edu or
rhibberd@umsl.edu. They would be grateful for your time and help with
the study.
To participate, click here:
http://www.surveymonkey.com/s.aspx?sm=5yrtsekszBIFIlBYKlibIw_
3d_3d
WANTED:
Participants for Diabetes Survey
Study examining the attitudes of people with diabetes. We are collecting our data through a brief online survey.
We are offering $5 Amazon.com gifts certificates as an incentive for study participants. Our goal is to recruit 160 study participants.
To take part in the study follow the link.
https://www.surveymonkey.com/s.
aspx?sm=nYA9MV6MP5GQMRptcDkN0Q_3d_3d
For more information contact Kate Ward at kate.c.ward@gmail.com.
WANTED:
Type 1 Diabetes Study
Type 1 Diabetes: How does it affect you? You may have the opportunity to change the way it affects others. Profil Institute for Clinical Research is conducting research with an investigational insulin for people who have Type 1 Diabetes.
Participants must be:
- Diagnosed with Type 1 Diabetes for at least 1 year
- Between 18 and 55
- Otherwise healthy
You may be compensated up to $2,750.00 for your time. Four overnight stays are required.
For more information, please call: 619-409-1244. E-mail: volunteer@profil-research.com
WANTED:
Type 1 Diabetes Study
Do you have Type 1 Diabetes?
- Have you been on a stable insulin regimen for at least 2 months?
- Would you like to try a new delivery system for managing your diabetes?
- Are you a non-smoker?
- Are you at least 25 years old?
If you answered yes to all of the above questions, you may be eligible to participate in a clinical trail using inhaled insulin. Qualified participants will receive confidential study-related medical exams, blood exams, inhaled or subcutaneous insulin as study medication, and a blood sugar testing device at no charge.
For more information, please contact:
Diablo Clinical Research
Bonnie 925-930-7267 ext. 258
WANTED:
Type 2 Diabetics:
You should know…
… many Type 2 Diabetics need to take insulin to better control their diabetes.
Sometimes diet and lifestyle changes are not enough. Controlling diabetes is important to avoid future health complications. Insulin along with oral anti-diabetic treatments and a healthy lifestyle can help control blood sugar in type 2 diabetics. A clinical research study is being conducted in your area to compare the effectiveness of two forms of insulin – injected and inhaled – in controlling blood sugar levels when used with other diabetes treatments. Both insulin treatments have already been approved.
If you are between the ages of 30 and 75, on 2 or more oral diabetic agents and have been a non smoker for at least 6 months, you may qualify for this study.
This study includes an initial consultation, study medication and follow up exams. Compensation for time and travel may be provided. If you are interested in learning more and taking a confidential self-screener, please visit our website at: www.theinsulinstudy.com/index.asp?c=DL
WANTED:
Type 2 Research Study Volunteers
NYU School of Medicine is looking for adults and young people with type 2 diabetes to participate in an ongoing research study. Participants must live near the NYC area, and must not be receiving insulin treatment. Adults should be between the ages of 45-65 years old, and young people between 14-21 years old. All participants will be financially compensated for their time. For more information, please e-mail arenta01@med.nyu.edu. Include your name, age, and contact information.
WANTED:
Research Study Volunteers
Allison Radcliffe is seeking people with Type I diabetes to take part in a research study to test how different methods of dealing with stress can improve the health and functioning of people with diabetes. Allison states, “As anyone with diabetes knows, the combination of stressful life events and the demanding daily requirements of the disease can worsen diabetes, because it is influenced by stress.”
If you are interested in learning more about this study, and possibly participating, please go to www.clas.wayne.edu/~radcliff/. If at any point you have questions, please email the research team at diabetes_research@wayne.edu.
WANTED:
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
This study is currently recruiting patients.
Verified by Sangamo Biosciences January 2007
Sangamo Biosciences ClinicalTrials.gov Identifier: NCT00406458
Purpose
The purpose of the study is to study the clinical effects of the investigational drug, SB-509 vs. placebo in patients with diabetic neuropathy.
- Condition Intervention Phase
- Diabetes Type I or II Mild to Moderate Sensori-Motor Diabetic Polyneuropathy Gene Transfer: SB-509 (VEGF Zinc-finger protein activator)
- Study Type: Interventional
- Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
- Official Title: A Phase 2 Repeat Dosing Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
- Further study details as provided by Sangamo Biosciences:
- Primary Outcomes: Visual Analog Scale for Pain Intensity (VASPI); Total Neuropathy Score (TNS); Nerve Conduction Velocity (NCV); Quantitative Sensory Testing (QST); Epidermal Nerve Fiber Density
- (ENFD); Epidermal Nerve Fiber Density Regeneration (ENFDR)
- Secondary Outcomes: Safety, Clinical Labs
- Expected Total Enrollment: 102
- Study start: November 2006; Expected completion: November 2008
- Last follow-up: September 2008; Data entry closure: October 2008
- SB-509 contains the gene (DNA-a kind of biological “blueprint”) for a protein. When a researcher injects SB-509 into your legs, the drug enters the muscle and nerve cells around the injection site and causes these cells to make a protein. This protein causes your cells to increase production of another protein called vascular endothelial growth factor (VEGF), which may improve the structure and function of nerves. In addition, there are changes in the levels of 28 additional proteins in your cells. These proteins function to promote the growth of cells, are structures in cells, help synthesize products, and affect immune cells, and some have unknown functions. This increase in your own VEGF proteins may protect and repair the damaged nerves caused by diabetic neuropathy.
The study doctor will test SB-509 (60 mg) and placebo. Everyone in this study will receive intramuscular (IM-directly into the muscle) injections into both legs. This will happen 3 times over about 4 months. Two out of every 3 participants will receive SB-509 and 1 out of every 3 will receive placebo. You will not know, and the study doctor will not know, whether you will receive SB-509 or whether you will receive placebo.
Eligibility
Ages Eligible for Study: 18 Years - 65 Years, Genders Eligible for Study: Both
Criteria
Key Inclusion Criteria:
- Have a clinical diagnosis of Diabetes Mellitus Type I or II for at least 12 months prior to the study.
- Have received a diagnosis of mild to moderate sensori-motor diabetic neuropathy from a neurologist (a doctor who specializes in disorders of the nervous system) or endocrinologist (a doctor who specializes in diabetes). This type of neuropathy is a loss of sensation and muscle function that occurs in the legs and hands in a stocking and glove distribution. Subjects with diabetic neuropathy that results in loss of sensation or muscle function in only one nerve and results in loss of nerve function of the blood vessels and causes low blood pressure, will not be eligible.
- If female and of childbearing potential, agree to use a medically acceptable physical barrier method during the study.
- Have blood pressure < 140/90 mm Hg
- BMI < 38 kg/m2
Key Exclusion Criteria:
Subjects with the following are NOT eligible to participate in this study:
- Have moderate to severe ischemic heart disease, any history of congestive heart failure or have had a myocardial infarction (heart attack) within the previous 6 months.
- Have chronic foot or leg ulcers for >1 month, gangrene in the legs, or any previous amputation of the lower extremity.
- Have symptoms of intermittent claudication (or leg pain during exercise associated with peripheral artery disease) and/or an ankle brachial index (or a calculation of the difference between arm and leg blood pressures) of less than < 0.75.
- Have a history of cancer within the past 5 years (except curable non-melanoma cancer of the skin, superficial bladder cancer in complete remission, or any other cancer that has been in complete remission for at least 5 years).
- Have colon polyps. If you have history of benign colonic polyps that have been removed, you must have evidence of a normal colonoscopy within the last 12 months.
- Require any drug that depresses your immune system (such as methotrexate, cyclophosphamide, or cyclosporine) when you receive the study drug and for 30 days afterwards.
- Have a known disorder that affects your immune system (such as HIV/AIDS, HBV, HCV, sarcoidosis, tuberculosis, rheumatoid arthritis, or autoimmune disorders).
For more information contact:
Bonnie Smith
Diablo Clinical Research
2255 Ygnacio Valley Rd, Suite M
Walnut Creek, CA 94598
925-930-7267 x 258
bsmith@diabloclinical.com
WANTED:
Investigation monoclonal antibody study for people with Type 1 Diabetes Mellitus
People between the ages of 18 and 60 with Type 1 Diabetes Mellitus are needed to participate in a research study of an investigational monoclonal antibody. There is no charge for study visits. Most study visits take place over a 12 week period with periodic follow-up for 4 years. Qualified participants may be compensated for time and travel required.
Study inclusion / exclusion criteria
Men or Women of any race between 18-60 years old who are generally in good health and with a history of type 1 diabetes mellitus; must be willing come to the clinic for 8 sequential days of dosing; any existing medications must be on a stable dose for 4 weeks. Multiple blood draws will be required throughout this study. Interested patients must give informed consent and be willing to be evaluated via a physical examination and several laboratory tests prior to being allowed to participate. People with a prior history of HIV, tuberculosis, syphilis, hepatitis, spleen removal, severe allergic reactions, or alcohol or drug dependency or abuse are not permitted to participate in the study.
Diablo Clinical Research
2255 Ygnacio Valley Rd, Suite M
Walnut Creek, CA 94598
925-930-7267 x 258
bsmith@diabloclinical.com
WANTED:
Type 2 Diabetes for at least 10 years? CAN YOU HELP?
There is substantial information available on the genetic risks of diabetic kidney disease in patients with diabetes for Native-American, African-Americans and Mexican-Americans. There is little information about the same risks in European-Americans. We are studying the genes that may put a person with diabetes at a higher or lower risk of kidney complications .
- Are you of European descent?
- Have you had Type 2 diabetes for at least ten years?
- A free urine test which shows how well your kidneys are working is included as part of our study.
- You will be given a copy of the test results for your records.
- If you qualify, you will be asked about your medical and family history.
- Blood samples will be drawn by experienced staff.
- You will be compensated for your time and any inconvenience.
- Southern California residents preferred.
If interested, please call: 310-222-4104 or e-mail: kidneystudygroup@labiomed.org.
WANTED:
Vision Changes in Diabetes
Population needed: Adult males and females diagnosed with Type 1 or Type 2 diabetes
The University of California, Berkeley is conducting studies aimed at early detection of changes in vision and prediction of future sight-threatening diabetic retinopathy in individuals with diabetes.
To qualify you must:
- Be between the ages of 18 and 65
- Have had diabetes for at least eight years
- Have fairly good vision (with glasses or contacts if worn)
- Have no other eye diseases (such as glaucoma, cataract, macular degeneration)
- Have not had eye surgery
- Meet all other inclusion criteria
Qualified participants will receive at no cost:
- Study-related eye health assessment
- Study-related photographs of the back of the eye
- Study-related laboratory tests
Compensation for local travel will be provided.
For more information please call the Diabetes Study at 510-643-0507 or email
WANTED:
Research Study Type 2 Diabetes
In this study we are testing an investigational medication developed to provide glycemic control. We will be assessing is various doses of the medication along with other factors.
Requirements:
- 30-65 years old
- Diagnosed with Type 2 Diabetes
- Is diet controlled alone or stable on a single oral agent antihyperglycemic medication
- Women must be surgically sterile (hysterectomy, bilateral oophorectomy, or tubal ligation) or postmenopausal for greater than 1 year
- Available for 1, 5 night stays, 2, 1-night stays and 10 outpatient visits at our facility in Tacoma, WA
Stipend: up to $1,750 for time and travel expenses
Please note:
All personal health information submitted by online registration will be added to our database with your approval. All information remains confidential within our database at Northwest Kinetics, and is not shared with outside parties.
If you agree to be contacted for this trial or future trials, your contact information will be used to reach you by phone or email.
For more information: Please call the Recruiters at Northwest Kinetics, at 1-877-NWSTUDY, or 253-779-8815, or email to recruiters@nwkinetics.com. October 4, 2006
WANTED:
Could Diabetes be Affecting Your Health?
If you suspect or know you have diabetes and are not taking medication to treat it, you may qualify to join a nationwide research program.
This program offers:
- Thorough helth evaluations
- Diabetes education
- nutritional counseling
- investigational medication
Compensation for participation can be up to $700 if you qualify. There are no costs to you and no insurance is needed. For more information call Bayview Research Group in Studio City, CA at (800) 831-8308 ext. 101. September 19, 2006
WANTED:
Diabetic Nephropathy Study
We need people like you
According to the Centers for Disease Control, approximately 18.2 million people in the U.S. suffer from diabetes. Of these, it is estimated that 40% will develop diabetic nephropathy (kidney disease related to their diabetes.) While there are currently medications used to help in the treatment of the kidney disease, not all medications work well with everyone.
Today local doctors are looking for adults struggling with diabetic nephropathy to help evaluate an investigational medication for the disease. By looking for treatments that slow down the progression of diabetic nephropathy, it may someday be possible to delay the need for dialysis or transplant. You will be under no obligation to participate, and the information you submit will be held in confidence. For more information contact Thomson CenterWatch of Boston, MA at 617-856-5900. September 11, 2006
WANTED:
Research Study Type 2 Diabetes
Population needed: Males and Females diagnosed with Type 2 Diabetes
Description: In this study we are testing an investigational medication being designed to lower blood sugar in patients with type 2 diabetes. We will be assessing the treatment of this investigational medication as compared to a placebo. A variety of things will be assessed which includes but is not limited to the tolerability, safety, and how the medication is absorbed and processed by your body.
Requirements:
21-65 years old
Diagnosed with Type 2 Diabetes
Can refrain from prescription medication unless on a stable dose for at least 3 months
Has not had any recent changes in health or medication
Can refrain from herbal supplements 14 days prior to the start of the study
Women must be post menopausal for at least 2 years or have a documented hysterectomy or tubal ligation
Available for 2 overnight stays and 6 outpatient visits at our facility in Tacoma, WA
Stipend: up to $835.00 for time and travel expenses
Please note:
All personal health information submitted by online registration will be added to our database with your approval. All information remains confidential within our database at Northwest Kinetics, and is not shared with outside parties.
If you agree to be contacted for this trial or future trials, your contact information will be used to reach you by phone or email.
For more information: Please call the Recruiters at Northwest Kinetics, at 1-877-NWSTUDY, or 253-779-8815, or email to recruiters@nwkinetics.com. August 16, 2006
WANTED:
Research Study Type 2 Diabetes
Population needed: Males and Females diagnosed with Type 2 Diabetes
Description: In this study we are testing an investigational medication being designed to lower blood sugar in patients with type 2 diabetes. A variety of things will be assessed which includes but is not limited to the tolerability, safety, and how the medication is absorbed and processed by your body.
Requirements:
18-75 years old
Diagnosed with Type 2 Diabetes
Can refrain from prescription medication unless on a stable dose for 3 months or more
Can refrain from herbal supplements 14 days prior to the start of the study
Must be willing to use an acceptable form of birth control for the duration of the study
Available for 3 separate 2 night stays at our facility in Tacoma, WA
Stipend: up to $1,400.00 for time and travel expenses
Please note:
All personal health information submitted by online registration will be added to our database with your approval. All information remains confidential within our database at Northwest Kinetics, and is not shared with outside parties.
If you agree to be contacted for this trial or future trials, your contact information will be used to reach you by phone or email.
For more information: Please call the Recruiters at Northwest Kinetics, at 1-877-NWSTUDY, or 253-779-8815, or email to recruiters@nwkinetics.com. August 16th 2006
WANTED:
San Francisco Area Research Project: Exercise Training and Diabetes
The University of San Francisco and the University of California San Francisco Medical Center are conducting a 12-week research study looking at the effects of regular aerobic exercise and nutrition counseling on fitness and risk factors for heart disease. Study subjects must be Type 2 Diabetic females 45-75 years old. If interested in getting more information, please contact the University of San Francisco Research Hotline at 415-422-6614. July 11, 2006